Clinical Trials
3 trialsNCT01842321 2021-02-23
AMA
UNICANCER
Phase 2 Completed
NCT00755885 2017-01-26
Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
Cancer Research UK
Phase 1/2 Completed
NCT01814865 2013-12-20
Anti-Proliferative Effects and Genomic Alterations of Abiraterone Acetate Compared to an Aromatase Inhibitor in Post-menopausal HR+ Operable Breast Cancer
British Columbia Cancer Agency
Phase 2 Withdrawn